Literature DB >> 26806810

RETRACTED: MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma.

Jia Liu1, Yu Mao2, Dakai Zhang1, Shengnan Hao3, Zicheng Zhang4, Zhenjiang Li5, Baosheng Li6.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor in Chief. The term miR-143 has been used instead of the term miR-143* in the introduction and discussion which is misleading. With the misuse of this term subsequent errors and misleading statements appear throughout the paper. The authors apologize for this mistake.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; Progression; STAT3; miR-143

Mesh:

Substances:

Year:  2016        PMID: 26806810     DOI: 10.1016/j.canlet.2016.01.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer.

Authors:  Lufei Wang; Jin He; Hongmei Xu; Longjie Xu; Na Li
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Downregulation of RUVBL1 inhibits proliferation of lung adenocarcinoma cells by G1/S phase cell cycle arrest via multiple mechanisms.

Authors:  Xiao-Shuai Yuan; Zhi-Tian Wang; Ye-Ji Hu; Fei-Chao Bao; Ping Yuan; Chong Zhang; Jin-Lin Cao; Wang Lv; Jian Hu
Journal:  Tumour Biol       Date:  2016-10-10

3.  LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.

Authors:  Junhua Luo; Jing Chen; Hang Li; Yu Yang; Haichao Yun; Shangqi Yang; Xiangming Mao
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

4.  Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma.

Authors:  Bin Zhang; Rui Li; Chun-Xiao Chang; Yong Han; Sheng-Bin Shi; Jing Tian
Journal:  Onco Targets Ther       Date:  2016-06-29       Impact factor: 4.147

5.  Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.

Authors:  Yusaku Osako; Naohiko Seki; Yoshiaki Kita; Keiichi Yonemori; Keiichi Koshizuka; Akira Kurozumi; Itaru Omoto; Ken Sasaki; Yasuto Uchikado; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  Int J Oncol       Date:  2016-10-21       Impact factor: 5.650

6.  TGF-β signaling controls FSHR signaling-reduced ovarian granulosa cell apoptosis through the SMAD4/miR-143 axis.

Authors:  Xing Du; Lifan Zhang; Xinyu Li; Zengxiang Pan; Honglin Liu; Qifa Li
Journal:  Cell Death Dis       Date:  2016-11-24       Impact factor: 8.469

7.  cfa-miR-143 Promotes Apoptosis via the p53 Pathway in Canine Influenza Virus H3N2-Infected Cells.

Authors:  Pei Zhou; Liqing Tu; Xi Lin; Xiangqi Hao; Qingxu Zheng; Weijie Zeng; Xin Zhang; Yun Zheng; Lifang Wang; Shoujun Li
Journal:  Viruses       Date:  2017-11-25       Impact factor: 5.048

8.  Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.

Authors:  Xing Bao; Tingting Ren; Yi Huang; Shidong Wang; Fan Zhang; Kuisheng Liu; Bingxin Zheng; Wei Guo
Journal:  J Exp Clin Cancer Res       Date:  2016-08-30

9.  Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.

Authors:  Charles Johannessen; Line Moi; Yury Kiselev; Mona Irene Pedersen; Stig Manfred Dalen; Tonje Braaten; Lill-Tove Busund
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

10.  miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.

Authors:  Chao Lei; Feng Du; Lina Sun; Ting Li; Tingyu Li; Yali Min; Aiying Nie; Xin Wang; Lei Geng; Yuanyuan Lu; Xiaodi Zhao; Yongquan Shi; Daiming Fan
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.